Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma Luis. | June 5, 2023
/PRNewswire/ Sanctuary Wealth, home to the next generation of elite advisors, proudly announces that nine of its advisor partners have been named to the.